Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | ||||
---|---|---|---|---|---|---|---|---|---|
Sex | M | F | M | F | M | M | |||
Age of onset | 3 mo | 3 mo | 5 days | 2 mo | 1 mo | 1 mo | |||
Age at diagnosis | 9 mo | 6 mo | 1 mo | 11 yr | 8 mo | 1 yr | |||
Symptoms | Fever | + | |||||||
Feeding difficulty | + | + | + | + | + | + | |||
Vomiting | + | + | + | + | + | ||||
Poor weight gain | + | + | + | + | + | + | |||
Drowsiness | + | ||||||||
Deep respiration | + | ||||||||
Polydipsia | + | ||||||||
Polyuria | + | ||||||||
Urinary tract infection | + | ||||||||
Constipation | + | + | + | ||||||
Hypertension | + | ||||||||
Physical examination | |||||||||
Growth retardation | + | + | + | + | + | ||||
Dehydration | + | + | |||||||
Hypotonia | + | + | |||||||
History of vitamin D application | 400-500U/d (from neonatal period to 7 mo) | Oral calcium in infancy | Vitamin D 500IU/d in neonatal period, vitamin D3 300000IU once orally at 8 mo | vitamin D 500IU/d from 1 mo to 1 yr | |||||
Family history of renal calcification | - | Mother | Father | - | Father Grandmother Aunt | Father | |||
Laboratory findings | |||||||||
At initial presentation | Normal range | ||||||||
Serum Ca (mmol/L) | 3.79 | 4.19 | 4.31 | 2.35 | 3.36 | 2.88 | 2.1–2.8 | ||
Serum Pi (mmol/L) | 1.52 | 1.05 | 1.57 | 1.72 | 1.19 | 1.15 | 1.37–1.99 | ||
Serum Mag (mmol/L) | 0.74 | 0.85 | 0.86 | 0.91 | 0.58 | 0.81 | 0.8–1.2 | ||
ALP (U/L) | 260 | 124 | 178 | 436 | 154 | 329 | 143–406 | ||
PTH (pg/ml) | 1.00 | 1.00 | 0.01 | 31.58 | 2 | ND | 10–69 | ||
25(OH)D3 (nmol/L) | 30.8 | 25.3 | 24.4 | ND | > 400 | 77.4 | ≥ 50 | ||
1,25(OH)2D3 (pg/ml) | ND | ND | ND | 110 | ND | ND | |||
Urine Ca/Cr (mmol/mmol) | 1.67 | ND | ND | 3.19 | 1.35 | 0.24 | 0.00-0.20 | ||
24 h urine Ca (mmol/kg/24 h) | 0.22 | 0.22–0.31 | 0.17–0.22 | ND | 0.21 | ND | < 0.2 | ||
GFR (mL/min/1.73 m2) | 84.2–127.0 | 42.5–94.7 | 45.9 | 89.7 | 66.9-136.3 | 104.2 | < 90 | ||
At last observation | |||||||||
Age | 2 year 6 mo | 6 year 8 mo | 4 mo | 13 year | 1 year 5 mo | 1 year 5 mo | |||
Serum Ca (mmol/L) | 2.2 | 2.40 | 2.55 | 2.45 | 2.56 | 2.45 | 2.1–2.8 | ||
Serum Pi (mmol/L) | ND | 1.57 | 1.9 | ND | 1.87 | 1.37 | 1.37–1.99 | ||
ALP (U/L) | ND | 270 | 320 | ND | ND | 44.8 | 143–406 | ||
PTH (pg/ml) | ND | ND | 1.2 | ND | ND | ND | 10–69 | ||
Urine Ca/Cr (mmol/mmol) | ND | 0.09 | 0.44 | 0.16 | ND | 0.09 | 0.00-0.20 | ||
GFR (mL/min/1.73 m2) | ND | 131.7 | 100.6 | 77.7 | ND | 137.1 | < 90 | ||
Imaging examination | |||||||||
Nephrocalcinosis | + | + | + | + | + | + | |||
Skeletal abnormality | - | - | + | - | + | ND | |||
Parathyroid ultrasound | - | - | - | ND | - | ND | |||
Gene analysis | CYP24A1 c.116G > C het | SLC34A1 c.1322 A > G het | SLC34A1 c.1697_1698insT het | CYP24A1 c.1349T > C and c.287T > A | CYP24A1 c.823T > C and c.476G > C | SLC34A1 c.1726T > C het and CYP24A1 c.376 C > T het |